Blueprint Medicines Corporation (BPMC) Return on Investment ROI from the first quarter of 2025 to first quarter of 2024 and for the year 2025, average high and low, overall ranking from Mar 31 2025 to Mar 31 2024 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Blueprint Medicines Corporation  (NASDAQ: BPMC)


Blueprint Medicines's ROI from its first quarter of 2025 to the first quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Blueprint Medicines's ROI in the first quarter of 2025?
Blueprint Medicines Corporation recorded a cumulative net loss of $-156 million during 12 months ending in the first quarter of 2025, resulting in a negative return on investment (ROI) of -16.54%.

Within the Healthcare sector 290 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Mar 31 2025 quarter, so far to 3255, from total ROI ranking in the fourth quarter of 2024 at 3483.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter
Y / Y Investment Change TTM 7.24 % -2 % -12.11 % -20.31 % -22.5 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 945 919 942 960 832
Return On Investment (TTM) -16.54 % -7.35 % -14.36 % -23.26 % -32.84 %
BPMC's Overall Ranking # 3255 # 3483 # 3311 # 3511 # 3759
Seq. Investment Change TTM 3.1 % 2.37 % 0.96 % 0.64 % -5.79 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -156 -67 -128 -205 -288

BPMC Company Profile >> Back to BPMC Roi Comparisons >> See Annual BPMC Return On Investment



Return On Investment BPMC's Ranking
Within: No.
Industry # 104
Sector # 291
Overall # 3255

Return On Investment Statistics
High Average Low
37.26 %
-33.35 %
-63.01 %
(Sep 30 2020)   (Sep 30 2022)







Financial Statements
Blueprint Medicines's I. Quarter Investments $ 945 Millions BPMC's Balance sheet
Blueprint Medicines's I. Quarter Income $ 0 Millions Quarterly BPMC's Income Statement
BPMC's Income by Division See BPMC's Income by Division


BPMC Annual Return On Investment (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020
Total Investments in Millions 919 834 1,167 1,102 1,588
Y / Y Investment Growth 10.15 % -28.49 % 5.82 % -30.56 % 164.07 %
Net Income in Millions -67 -507 -558 -644 314
Y / Y Net Income Growth - - - - -
Annual Return On Investment -7.3 % -60.77 % -47.79 % -58.42 % 19.77 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
BPMC's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for BPMC's Competitors
Subscribers only: Roi for Blueprint Medicines's Suppliers
Subscribers only: Return On Investment for BPMC's Customers

Other Ratios
BPMC's Roa BPMC's Inventory Turnover Ratio BPMC's Growth Rates BPMC's Dividend Statistics
BPMC's Profitability Ratios BPMC's Asset Turnover Ratio BPMC's Dividend Growth
BPMC's Roe BPMC's Valuation Ratios BPMC's Financial Strength Ratios BPMC's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2025, within Healthcare Sector ROI

Date modified: 2026-09-08T16:52:23+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.